IFNA1 and COVID-19: They may also directly inhibit IFN production and signaling, as suggested by patients with mild coronavirus disease 2019 (COVID-19) demonstrating early and strong IFN responses whereas those with severe disease showing a deficiency in IFN synthesis [38,39].